News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall     7/9/2015
Johnson & Johnson (JNJ) HIV Vaccine Blocks Virus in 50% of Monkeys, Soon to Start Human Trial in 400     7/9/2015
EXCLUSIVE: Cancer Therapy Benefits Realized Long After FDA Approval, Study Author Tells BioSpace (DHX)     6/29/2015
Exciting Time for Biotech in New Jersey     6/29/2015
GlaxoSmithKline (GSK), University of North Carolina Set Up $20 Million Spinoff to Find a Cure for HIV/AIDS     5/12/2015
Gilead (GILD)'s Next-Gen HIV Drug Heads to the FDA, Stock Soars     4/10/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
CALBIO15: Bill & Melinda Gates Foundation Exec Says Ebola Vaccine Will Arrive in 2016, Takes Aim at Vaccination Critics     3/3/2015
Gilead (GILD)'s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV     3/2/2015
Critics Attack as Gilead (GILD) Has a Pill to Stop HIV, But Why Isn't Anyone Taking It?     2/23/2015
TRICON: Chimerix (CMRX): Antivirals Are Undergoing a Renaissance, As Infectious Disease Comes Front and Center     2/18/2015
FDA Green Lights Bristol-Myers Squibb Company (BMY), Johnson & Johnson (JNJ) HIV Pills     1/30/2015
Strides Arcolab Limited Snags Huge HIV Pact With Gilead Sciences, Inc. (GILD)     1/20/2015
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ) Expand Existing HIV R&D Pact     12/29/2014
S.F. Men Shed Condoms In Favor Of Gilead Sciences, Inc. (GILD)'s HIV Prevention Pill Truvada     12/9/2014

News from Around the Web
2-Pound DNA-Reader Could Help Fight Ebola, TB, HIV     7/30/2015
Teen's HIV In Remission Despite Stopping Treatment As A Child, Pasteur Institute Reveals     7/21/2015
$4 Million Boost To Turn The Tide On AIDS In Cuyahoga County     7/7/2015
Cuba Becomes First To Eliminate Mother-To-Child HIV     7/1/2015
Vitamin D May Help Fight HIV, Penn State University Study     6/19/2015
Dirty Needles Spread HIV In Indiana As Pain Pills Injected     3/30/2015
Give HIV Drugs To Healthy Gay Men, UK Medical Research Council (MRC) Reveals     2/25/2015
Bill Gates Predicts An HIV Vaccine By 2030     1/30/2015
Birth Control Shot Linked To Increased HIV Risk, University of California, Berkeley (CAL) Study     1/12/2015
The Reason Why Experimental HIV Vaccines Backfire, Emory University Study Suggests     1/7/2015
New Technique For Bioengineering Stem Cells Shows Promise In HIV Resistance, University of California, Davis (UCD) Study     1/2/2015
AIDS Drug Also Offers Protection Against Malaria, Yale University Study Finds     12/22/2014
University of Oxford Research Suggests Ability Of HIV To Cause AIDS Is Slowing     12/2/2014
2nd Baby Cured Of HIV Relapses, Lancet Reveals     10/3/2014
Teen’s Organs Rejected Because He’s Gay     8/18/2014

Press Releases
Bio-Rad (BIO) Announces U.S. FDA Pre-Market Approval For The BioPlex 2200 HIV Ag-Ab Assay, A Novel Next Generation HIV Diagnostic Test     7/29/2015
CytoDyn Completes Qualification Of PRO 140 Material For Phase III     7/29/2015
New amfAR Grants Accelerate Research Efforts To Eradicate HIV     7/28/2015
Bristol-Myers Squibb (BMY) Release: Second-Generation Investigational HIV-1 Maturation Inhibitor Demonstrates Positive New Phase IIa Results, Supporting Continued Development     7/22/2015
Entera Health Release: Study Shows Benefits Of EnteraGam For Patients With HIV-Associated Enteropathy     7/22/2015
Bristol-Myers Squibb (BMY) Nails FDA Breakthrough Designation for Next-Gen HIV-1 Attachment Inhibitor     7/21/2015
Merck & Co. (MRK) Marks 30-Year Milestone In Commitment To Innovation And Care In HIV/AIDS     7/21/2015
InnaVirVax Presents Highly Encouraging Results Of Its First Clinical Study On VAC-3S Immunotherapy For HIV     7/20/2015
CEL-SCI (CVM) Expands Its Phase I Study For Treatment Of Anal Warts In HIV/HPV Co-Infected Patients With Addition Of 2nd Site At University of California, San Francisco (UCSF)     7/20/2015
THERAVECTYS To Present Detailed Phase I/II Results From The First-Ever Lentiviral-Vector Based Therapeutic Vaccine Trial At The 2015 Towards An HIV Cure Symposium     7/20/2015
European Commission (EC) Approves Bristol-Myers Squibb (BMY)’s Evotaz (Atazanavir And Cobicistat Fixed-Dose Combination) For The Treatment Of HIV-1 Infection In Adults     7/16/2015
CytoDyn Release: Evidence Of HIV Suppression With PRO 140 Monotherapy Reaching Nearly 11 Months     7/15/2015
GeoVax, Inc. Receives Grant From NIH For HIV Vaccine Program     7/2/2015
International AIDS Vaccine Initiative Release: AIDS Vaccine Candidate Successfully 'Primes' Immune System In Animal Models     6/19/2015
CytoDyn Cleared By FDA To Start Phase III Of First Injectable Antibody For HIV     6/9/2015

//-->